Kinnevik AB
BBG000BP73C4
ISIN SE0015810247 / Valor 111165520
Kinnevik AB
UMushroom community rating:
About company
Kinnevik AB is a prominent investment company based in Europe, with a history dating back to 1936. The company specializes in investing in digital companies, focusing on sectors such as healthcare, software, marketplaces, and climate tech. With a net asset value of SEK 48.2 billion as of December 31, 2023, Kinnevik supports over 30 investee companies, aiming to drive significant returns by understanding complex consumer behaviors and backing companies that reimagine everyday life. The portfolio composition reflects a diverse investment strategy, with allocations in healthcare (25%), software (19%), marketplaces (10%), and other areas including consumer finance and early-stage ventures. Kinnevik's approach is characterized by its support for challenger companies that have the potential to lead their respective industries.
Summarized from source with an LLMView SourceSector: FinanceLatest Results (15.05.2024):
Q1 2024: Financial Update on Software and Healthcare Technology
In Q1 2024, Kinnevik AB reported that its Software and Virtual Care companies are growing at a rate of 2-3 times faster than the fastest growing public comparables. Despite this rapid growth, these companies are valued almost in line with the average EV/GP levels, indicating a strong but balanced market valuation.
Q1 2024: Core Growth Companies' Performance
Kinnevik AB's core growth companies showed a flat performance in local currencies on average during Q1 2024. A significant factor was the rebasing of Cityblock’s valuation multiple, which impacted the group’s average development negatively in this quarter.
Q1 2024: Revenue Growth and EBITDA Margin
As of Q1 2024, Kinnevik AB's core companies have managed the growth-profitability trade-off effectively over the past 2-3 years. By the end of 2024, these companies are expected to be EBITDA positive on an average basis while maintaining a growth rate exceeding 40%.
Q1 2024: Private Company Valuation Changes
During Q1 2024, Kinnevik AB experienced the largest valuation revisions with VillageMD and Cedar, leading to a 5% decrease in the private portfolio’s fair value to SEK 27.3 billion. These adjustments reflect changes in market conditions and company performance.
Q1 2024: Reporting Changes and NAV Categorization
Kinnevik AB has made significant changes to the categorization of its Net Asset Value (NAV) in Q1 2024 to better reflect its portfolio and investment strategies. This includes breaking out "Climate Tech" as a separate category and consolidating all healthcare investments into "Health & Bio," enhancing clarity and focus in financial reporting.
Summarized from source with an LLMView SourceKey figures
Performance
Volatility
2873 M
Market cap (USD)
1,777,349
Daily traded volume (Shares)
126.1 / 121.55
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
